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Abstract
Background:  Hepcidin/LEAP-1 is an iron regulatory hormone originally identified as an
antimicrobial peptide. As part of a systematic analysis of the evolution of host defense peptides in
primates, we have sequenced the orthologous gene from 14 species of non-human primates.
Results: The sequence of the mature peptide is highly conserved amongst all the analyzed species,
being identical to the human one in great apes and gibbons, with a single residue conservative
variation in Old-World monkeys and with few substitutions in New-World monkeys.
Conclusion: Our analysis indicates that hepcidin's role as a regulatory hormone, which involves
interaction with a conserved receptor (ferroportin), may result in conservation over most of its
sequence, with the exception of the stretch between residues 15 and 18, which in New-World
monkeys (as well as in other mammals) shows a significant variation, possibly indicating that this
structural region is involved in other functions.
Background
Antimicrobial peptides (AMPs) are phylogenetically
ancient and ubiquitous molecules that play an essential
role in many aspects of host defence [1]. In plants and
invertebrate animals they are central to protecting the host
from infection, while in vertebrate animals that have
developed an acquired immunity they not only provide a
rapidly mobilised first line of defence as part of the innate
immune system, but also act as signalling molecules to
cellular components of both innate and adaptive immu-
nity [2]. Being at the interface between host and commen-
sal or pathogenic microbes, they generally undergo an
accelerated evolution, which has resulted in many differ-
ent AMP families and a remarkable sequence variation
even within structural groups [3].
In some cases, molecules derived from AMPs have
acquired functions beyond host defence, although they
can maintain a role in the prevention of infection. The
recently identified peptide hepcidin/LEAP-1 is a good
example. It was independently isolated from human urine
and plasma ultra filtrate, respectively, by two groups
searching for novel AMPs. Both denominations thus
reflect its hepatic expression (hep- or Liver Expressed) and
its antimicrobial activity in vitro (-cidin, or Antimicrobial
Peptide) [4,5]. Subsequently, the observation that disrup-
tion or mutation of the hepcidin gene in mouse and man
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results in severe forms of iron overload identified it also as
a negative regulator of iron absorption, recycling and
release from stores [6-8]. It functions by inducing the
internalisation of the ubiquitous, vertebrate, iron export
membrane protein ferroportin, at the major sites of iron
flow (enterocytes, tissue macrophages and hepatocytes),
causing a decrease in serum iron levels. It was thus pro-
posed that hepcidin was the long sought iron regulatory
hormone, whose synthesis is controlled by iron levels and
erythroid demands [9,10]. Hepcidin maintains a role in
host defence by acting as a bridge between immunity and
iron-metabolism, as indicated by the fact that it is mark-
edly induced by infection and inflammation [7,8,11].
This likely reflects an antimicrobial action via iron limita-
tion rather than a direct antimicrobial activity [12,13].
In humans, hepcidin is encoded by three small exons in
the HAMP gene (19q13.1), and translates to an 84aa pre-
propeptide presenting a furin cleavage site. It is expressed
and processed predominantly in liver for plasma delivery,
and it is excreted by the kidney. In urine, the predominant
form is of 25 amino acids (hep-25) with a charge of +2,
but two shorter, inactive peptides (hep-22 and hep-20)
were also detected [4]. It does not show significant
sequence similarity to any other known AMP, but it has
been associated with the defensin family of host defence
peptides due to its salt-sensitive antimicrobial activity in
vitro, cationic and amphipathic nature, and the presence
of 4 disulfide bridges in its tertiary structure. However,
unlike defensins, it assumes a hairpin conformation
which is stabilised by four S-S bridges placed in a ladder-
like manner, including an unusual and possibly reactive
vicinal disulphide. Structurally, it is therefore more remi-
niscent of AMPs such as protegrin [8]. It is not clear
whether the observed in vivo antimicrobial activity is bio-
logically relevant, is simply a residue of a possible evolu-
tionary origin as an AMP, or derives from the conserved
structural characteristics imposed by its function as an
iron-regulating hormone.
Hepcidin homologues and putative hepcidin precursors
have been identified in several vertebrate animals, ranging
from mammals and birds to amphibians and fish
[11,13,14]. Homology amongst the mature peptide
sequences is quite high, reflecting a high degree of struc-
tural conservation and pointing to a role as iron regula-
tory hormones also in non-mammalian animals. Some
species however express more than one hepdicin gene,
whose products may have functions other than iron regu-
lation, and in fish they may indeed still act as AMPs
[11,13]. It has in fact been hypothesised that the iron-reg-
ulatory hormones have evolved from ancient fish AMPs.
We have sequenced the hepcidin gene coding region (all
three exons) in 14 non-human primate species and com-
pared it with the human one (HSS), so as to gain informa-
tion about its evolution in primates and determine
whether it could usefully contribute to their phylogenetic
analysis. This study was carried out in the context of a
broader analysis of primate host defense peptide evolu-
tion, which has included the cathelicidin LL-37 and beta-
defensins, and which has shown remarkably varied pat-
terns of molecular evolution, ranging from conservation
to positive selection for variation [15,16]. By investigating
the degree of variation of the hepcidins in the closely
related primate species we aimed to determine the extent
of purifying selection during the evolution of this gene in
primates and locate regions of variation that could pro-
vide useful information on the functional determinants of
this multifunctional peptide hormone.
Results
The HAMP gene nucleotide sequences obtained from the
analyzed primate species, and the deduced corresponding
amino acid sequences, are reported in Figures 1 and 2.
They clearly demonstrate a high identity to the human
sequence at both the nucleotide and amino acid levels.
The nucleotide identity for the entire coding and untrans-
lated (UTR) regions ranges from 99.7% with chimpanzee
(PTR) to 92.6% with the NWM Ateles fusciceps (AFU). An
in-frame insertion of three nucleotides (namely GGA,
leading to the insertion of a glycine between residue 38
and 39 of the pre-propeptide) occurs in Hylobates.
At the amino acid level, identity ranges from 98.8% in
chimpanzee (PTR) to 83.3% in NWM Ateles (AFU) (see
Table 1).
The HAMP gene coding sequences were then used to com-
pute an UPGMA tree with all primate sequences, using the
Canis lupus familiaris HAMP gene as the outgroup [17]
(Figure 3), which reflects the expected phylogenetic rela-
tionship both among families and between families. A
maximum-likelihood approach, using the PAML suite of
programs, was then used to determine if positive selection
acted on the primate HAMP genes, and globally found
that it has not (ω<1). However, a site-analysis found that
individual amino acid residues may be under positive
selection (ω>1), including the Gly insertion between resi-
due 38 and 39, and Phe39Gln and Gln40Leu substitu-
tions in the Hylobates sequences (see Figure 2), and the
His74Arg, Arg75Gln and Ser76Pro substitution specific to
the NWM sequences. A subsequent branch-analysis also
indicated that although the mean ω is <1 over the entire
tree, positive selection may act on the Hylobates and NWM
branches, confirming the site-analysis data.
Discussion
To assess whether the variations found at the amino acid
level in the different primates species could have func-BMC Genomics 2008, 9:120 http://www.biomedcentral.com/1471-2164/9/120
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tional implications, these were analyzed in relation to the
available data for the structure and activity of the human
hepcidin, dividing the amino acid sequence into three
parts, namely signal peptide, pro-region and mature pep-
tide region (see Figure 2).
The entire sequence is quite conserved, but more so at the
level of the mature peptide. In effect, the only significant
variation in the pro-region corresponds to the insertion
observed for the Hylobates species, whose effect is unpre-
dictable as it falls outside the mature peptide. The putative
mature peptide sequence is identical to the human one in
great apes and gibbons, and shows a single conservative
Lys83Arg variation in Old-World monkeys. Interestingly,
a heterozygous Lys83Arg replacement leading to a peptide
identical to that of the OWMs has been found in a patient
with porphyria cutanea tarda and iron overload, but test-
ing of the synthetic homologue revealed it to remain fully
functional in iron regulation, so the effective role of this
substitution is not yet clear [18]. Other mutations in the
hepcidin gene previously reported to be associated with
hemochromatosis in humans [19-21] were not found in
the primate species examined (at least 5 individuals per
species have been studied).
The pro-peptide convertase cleavage site, the functionally
essential N-terminal region [18] and residues Phe4, Pro5,
Phe9, and Met21 that are involved in the oligomerization
of hepcidin-25 [22] are all conserved, as well as all
cysteine residues that account for the formation of disul-
phide bond and confer hepcidin's characteristic structure.
Only the New-World monkeys show significant variation
in a stretch between residues 15 and 18 of the mature pep-
tide sequence (74His, 75Arg and 76Ser, using the full pro-
peptide sequence numbering) (see figure 3) which may be
under positive selection. Alignment of the primate
sequences with those of other mammals, as well as bird,
amphibian and fish sequences [11,13,14], indicate that
this region is in fact the most variable also with respect to
other mammalian sequences (see figure 4a). This stretch
is just C-terminal to the two Cys residues forming the vic-
inal disulphide at the peptide's hairpin turn (see figure
4b) [22], which may be functionally significant. While the
conserved N-terminal region is recognised to be essential
Alignment of nucleotide sequences from coding and UTR regions of orthologous primate hepcidin genes Figure 1
Alignment of nucleotide sequences from coding and UTR regions of orthologous primate hepcidin genes. The 
UTR regions are underlined. Dots indicate nucleotide identity with the human sequence (GeneBank accession number: 
NM_021175). Non-synonymous substitutions are indicated in bold.BMC Genomics 2008, 9:120 http://www.biomedcentral.com/1471-2164/9/120
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for interaction with ferroportin [18], the role of the C-ter-
minal side is not well defined.
Shi et al [13] have hypothesized that, during vertebrate
evolution, hepcidin differentiated its functions towards
an iron-regulatory hormone starting from a more ancient
peptide characterized by antimicrobial activity. In this
respect, it is interesting to note that substitutions in the
variable region, concerning both primates and other ani-
mals, often concerns charged residues (see Figure 4);
moreover, it has been shown for different types of AMPs
that variation in charge are also favoured by positive selec-
tion [15,23]. Whereas for the latter peptides, charge mod-
ulation can be directly related to the efficiency of
interaction with microbes, thus affecting antimicrobial
activity, in the case of hepcidin, the effect of this variation
on function/s is an open question.
Conclusion
Our results indicate that hepcidin is quite conserved in all
primate species. This may derive from the fact that its role
as an iron regulating hormone requires interaction with
the conserved vertebrate iron transporter ferroportin [24].
In this context, while some types of residue variations,
such as those observed in mouse hepcidin 2 [13], can
result in a loss of the iron regulatory role, other variations,
such as those observed in the stretch between residues 15
and 18 in NWM and other mammals, can more freely
occur without apparently disrupting the hormonal func-
tion. It remains to be established whether these residues
are involved in other possible functions of the hepcidin
peptides, consistent with the possibility that they evolved
under positive selection.
Methods
Samples
We have analyzed the HAMP gene in three species of
great apes [Pan troglodytes (PTR), Gorilla gorilla (GGO),
Pongo pygmaeus (PPY)], two species of Hylobatidae [Hylo-
bates lar (HLA) and Hylobates concolor (HCO), now clas-
sified as Nomascus concolor], seven species of
Cercopithecidae [Old World Monkeys (OWM) ; Presbytis
obscurus (POB), Presbytis cristata (PCR), Presbytis melalo-
phos (PME), Papio papio (PPA), Macaca fascicularis (MFA),
Macaca fuscata (MFU), Cercopithecus aethiops (CAE)], and
Table 1: Percent identity of nucleotide (nt) and amino acid (aa) sequences calculated versus the human sequence. The highest and 
lowest values per each kind of identity (nt and aa) are underlined.
PTR GGO PPY HCO HLA POB PCR PME MFU PPA MFA CAE CJA AFU
nt identity 99.7 99.2 98.5 96.7 96.2 97.2 96.2 96.2 95.9 96.4 96.4 95.2 94.2 92.6
aa identity 98.8 96.4 96.4 92.9 91.7 97.6 97.6 97.6 94 95.2 95.2 94 88.1 83.3
Alignment of primate hepcidin deduced amino acid sequences Figure 2
Alignment of primate hepcidin deduced amino acid sequences. Dots indicate residue identity with the human 
sequence (GeneBank accession number: NP_066998). The signal peptide region is underlined and the mature peptide sequence 
is highlighted in grey.BMC Genomics 2008, 9:120 http://www.biomedcentral.com/1471-2164/9/120
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two Platyrrhine species [New World monkeys (NWM);
Callithrix jacchus (CJA),  Ateles fusciceps (AFU)].
We tried to minimize this risk of nucleotide intra-specific
variations, by analyzing more than one individual for
each species and determining a consensus sequence. This
method allowed us to clear our data for single nucleotide
polymorphisms variations in most species.
DNA extraction
Genomic DNA was extracted from hairs, liver, and muscle
tissues of primates as described previously by Del Pero et
al. [25] and Boniotto et al. [26], using the DNeasy Tissue
kit (Qiagen).
PCR and sequencing
Genomic DNA amplification of the hepcidin three exons
was performed using primers (see Table 2), designed on
the basis of the human sequence available in GenBank
(NM_021175) using the Primer Express 2.0 software
(Applied Biosystems, Foster City, CA). The PCR reactions
were carried out in a Thermal cycler 9700 (Applied Biosys-
A) Alignment of primate hepcidins with those of other mammals, amphibians and fish Figure 4
A) Alignment of primate hepcidins with those of other mammals, amphibians and fish. Residues identical to the 
human sequence are highlighted in grey. Part of the pro-peptide corresponding to the consensus propeptide convertase (furin) 
cleavage site is shown in italics. Arrows indicate the residues that are involved in the oligomerization of human hepcidin-25. 
(GeneBank accession numbers for non-primate species: Pig NM_214117; Mouse-1 BC_02158; Mouse-2 AY_232841; Rat 
NM_053469; Pigeon see ref. [14]; Frog DN_020182; Zebra fish NM_205583; Salmon BQ_036900; Bass DQ_31605). B) Struc-
ture of human hepcidin-25, based on the coordinate file 1M4F.pdb. The structure schematically shows the ladder-like disul-
phide connectivity (numbered Cys residues are indicated) and location of the variable stretch (residues 15–18) in light grey.
Rooted phylogenetic tree based on primate hepcidin nucle- otide sequences, prepared using the UPGMA method and  using the Canis lupus familiaris sequence as outgroup  (GeneBank accession number NM_001007140) Figure 3
Rooted phylogenetic tree based on primate hepcidin 
nucleotide sequences, prepared using the UPGMA 
method and using the Canis lupus familiaris sequence 
as outgroup (GeneBank accession number 
NM_001007140)BMC Genomics 2008, 9:120 http://www.biomedcentral.com/1471-2164/9/120
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tems) using PCR Buffer 1×, 1 unit of Taq Gold, 0.4 mM
dNTPs and variant concentration of MgCl2 (from 1.5 to 3
mM). The amplification conditions were 30 sec at 95°C,
30 sec at variable annealing temperature between the dif-
ferent templates (from 52°C up to 60°C), 30 sec at 72°C
for 35 cycles. PCR products were observed, under UV
light, in a 2% agarose gel, stained with ethidium bromide.
DNA sequencing of PCR products was performed using
the BigDye Terminator Cycle Sequencing Ready Reaction
Kit v. 2.0 (Applied Biosystems). DNA sequences were
detected and analyzed on an automated ABI Prism 3100
Genetic Analyser (Applied Biosystems).
Sequence alignment and Data Analysis
Multiple alignment of the nucleotide and amino acid
sequences were performed using the program CLUSTAL
W [27].
A phylogenetic tree was obtained by the UPGMA method,
using the PHYLIP software package [28]. Maximum Like-
lihood analysis was performed with the PAML software
package [29] by comparing the log-likelihood ratios of the
data using different NS-sites models [30]. This type of
analysis is able to identify amino acid residues with high
posterior probabilities (greater than 0.95) of having
evolved under positive selection. ω ratios for the tree were
calculated using different models (free ratio, two- and
three ratio) [31].
GeneBank accession numbers for non-human primate species
Pan troglodytes (PTR): EU076436; Gorilla gorilla (GGO):
EU076444; Pongo pygmaeus (PPY): EU076437; Hylobates
concolor  (HCO): EU076448;  Hylobates lar (HLA):
EU076449; Presbytis obscurus (POB): EU076439; Presbytis
cristata  (PCR): EU076441;  Presbytis melalophos (PME):
EU076440; Papio papio (PPA): EU076438; Macaca fascicu-
laris  (MFA): EU076443;  Macaca fuscata (MFU):
EU076442; Cercopithecus aethiops (CAE): EU076446; Cal-
lithrix jacchus (CJA): EU076445;  Ateles fusciceps (AFU):
EU076447.
Authors' contributions
LS performed the molecular genetic studies and partici-
pated in data interpretation; MM carried out the molecu-
lar genetic studies; AP performed the sequence alignment
and evolutionary analysis; AT participated in the study
design and sequence analyses and wrote the manuscript.
SC conceived the study, and participated in its design and
coordination and revised the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
This study was supported by a grant 200502027001 from "Regione Friuli 
Venezia Giulia" and by a grant from IRCCS Burlo Garofolo (RC 2007).
References
1. Zasloff M: Antimicrobial peptides of multicellular organisms.
Nature 415(6870):389-95. 2002 Jan 24
2. Yang D, Chertov O, Oppenheim JJ: The role of mammalian anti-
microbial peptides and proteins in awakening of innate host
defenses and adaptive immunity.  Cell Mol Life Sci 2001,
58(7):978-89.
3. Tossi A, Sandri L: Molecular diversity in gene-encoded, cationic
antimicrobial polypeptides.  Curr Pharm Des 2002, 8(9):743-761.
4. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary anti-
microbial peptide synthesized in the liver.  J Biol Chem
276(11):7806-7810. 2001 Mar 16
5. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-
Knappe P, Adermann K: LEAP-1, a novel highly disulfide-bonded
human peptide, exhibits antimicrobial activity.  FEBS Lett
480(2–3):147-50. 2000 Sep 1
6. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn
A, Vaulont S: Lack of hepcidin gene expression and severe tis-
sue iron overload in upstream stimulatory factor 2 (USF2)
knockout mice.  Proc Natl Acad Sci USA 98(15):8780-5. 2001 Jul 17
7. Ganz T, Nemeth E: Iron imports: IV. Hepcidin and regulation
of body iron metabolism.  Am J Physiol Gastrointest Liver Physiol
2006, 290(2):G199-203.
8. Ganz T, Nemeth E: Regulation of iron acquisition and iron dis-
tribution in mammals.  Biochim Biophys Acta 2006, 1763(7):690-9.
9. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal
O:  A new mouse liver specific gene, encoding a protein
homologous to human antimicrobial peptide hepcidin, is
overexpressed during iron overload.  J Biol Chem
276(11):7811-9. 2001 Mar 16
10. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beau-
mont C, Kahn A, Vaulont S: The gene encoding the iron regula-
tory peptide hepcidin is regulated by anemia, hypoxia, and
inflammation.  J Clin Invest 2002, 110(7):1037-44.
11. Verga Falzacappa MV, Muckenthaler MU: Hepcidin: iron-hormone
and anti-microbial peptide.  Gene 364:37-44. 2005 Dec 30
12. Ganz T: Molecular control of iron transport.  J Am Soc Nephrol
2007, 18(2):394-400.
13. Shi J, Camus AC: Hepcidins in amphibians and fishes: Antimi-
crobial peptides or iron-regulatory hormones?  Dev Comp
Immunol 2006, 30(9):746-55.
14. Fu YM, Li SP, Wu YF, Chang YZ: Identification and expression
analysis of hepcidin-like cDNAs from pigeon (Columba livia).
Mol Cell Biochem 2007, 305(1–2):191-7.
15. Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Cro-
vella S, Tossi A: Evolution of the primate cathelicidin. Correla-
tion between structural variations and antimicrobial activity.
J Biol Chem 281(29):19861-71. 2006 Jul 21
16. Crovella S, Antcheva N, Zelezetsky I, Boniotto M, Pacor S, Verga
Falzacappa MV, Tossi A: Primate beta-defensins – structure,
function and evolution.  Curr Protein Pept Sci 2005, 6(1):7-21.
17. Fry MM, Liggett JL, Baek SJ: Molecular cloning and expression of
canine hepcidin.  Vet Clin Pathol 2004, 33(4):223-7.
18. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T: The N-
terminus of hepcidin is essential for its interaction with fer-
roportin: structure-function study.  Blood 107(1):328-33. 2006
Jan 1
Table 2: Primers used to perform the genomic DNA 
amplification. Additional couples of primers (e.g. 1N, 1NN and 2-
3N) were used for each amplicon as it was not possible to 
amplify DNA from all the primates using a single set (e.g. 1 and 
2–3).
EXON FORWARD PRIMER REVERSE PRIMER
1 5' tctctcccgccttttcgg 3' 5' tgaggcctggctctccc 3'
1N 5' gccttttcggcgccac 3' 5' agacgtcctgagctctgctca 3'
1NN 5' ccccataaaagcgactgtcac 3' 5' ctcccatccctgctgcc 3'
2–3 5' gtttaaaccacttggagaggagca 3' 5' acactcggcagagagaaaggac 3'
2-3N 5' gaggtccactgggcccc 3' 5' acatgacccaccaagcactg 3'Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2008, 9:120 http://www.biomedcentral.com/1471-2164/9/120
Page 7 of 7
(page number not for citation purposes)
19. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis
J, Loukopoulos D, Camaschella C: Mutant antimicrobial peptide
hepcidin is associated with severe juvenile hemochromato-
sis.  Nature Genet 2003, 33(1):21-2.
20. Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasi
V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VLC,
Livesey KJ, Tanphaichitr V, Rochette J, Robson KJH: Digenic inher-
itance of mutations in HAMP and HFE results in different
types of haemochromatosis.  Hum Molec Genet 12(17):2241-7.
2003 Sep 1
21. Matthes T, Aguilar-Martinez P, Pizzi-Bosman L, Darbellay R, Rubbia-
Brandt L, Giostra E, Michel M, Ganz T, Beris P: Severe hemochro-
matosis in a Portuguese family associated with a new muta-
tion in the 5-prime-UTR of the HAMP gene.  Blood
104(7):2181-3. 2004 Oct 1
22. Hunter HN, Fulton DB, Ganz T, Vogel HJ: The solution structure
of human hepcidin, a peptide hormone with antimicrobial
activity that is involved in iron uptake and hereditary hemo-
chromatosis.  J Biol Chem 277(40):37597-603. 2002 Oct 4
23. Semple CA, Rolfe M, Dorin JR: Duplication and selection in the
evolution of primate beta-defensin genes.  Genome Biol 2003,
4(5):R31.
24. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw
BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus
GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI:
Positional cloning of zebrafish ferroportin1 identifies a con-
served vertebrate iron exporter.  Nature  403(6771):776-81.
2000 Feb 17
25. Del Pero M, Boniotto M, Zuccon D, Cervella P, Spano A, Amoroso
A, Crovella S: Beta-defensin 1 gene variability among non-
human primates.  Immunogenetics 2002, 53(10–11):907-13.
26. Boniotto M, Antcheva N, Zelezetsky I, Tossi A, Palumbo V, Verga
Falzacappa MV, Sgubin S, Braida L, Amoroso A, Crovella S: A study
of host defence peptide beta-defensin 3 in primates.  Biochem
J 374(Pt 3):707-14. 2003 Sep 15
27. Aiyar A: The use of CLUSTAL W and CLUSTAL X for multi-
ple sequence alignment.  Methods Mol Biol 2000, 132:221-41.
28. Phylip software   [http://evolution.genetics.washington.edu/
phylip.html]
29. Yang Z: PAML: a program package for phylogenetic analysis
by maximum likelihood.  Comput Appl Biosci 1997, 13(5):555-6.
30. Yang Z, Nielsen R, Goldman N, Pedersen AM: Codon-substitution
models for heterogeneous selection pressure at amino acid
sites.  Genetics 2000, 155(1):431-49.
31. Yang Z: Likelihood ratio tests for detecting positive selection
and application to primate lysozyme evolution.  Mol Biol Evol
1998, 15(5):568-73.